Company: RPTX
Filing Date: 2025-11-17
Form Type: DEFA14A
Source: 0001193125-25-284040
Chunk: 56

Company: Repare Therapeutics Inc.
Filing Date: 2025-11-17
Form: DEFA14A
Chunk 56
---
 or reserved, so as to enable the Effective Date to 
 occur as soon as reasonably practicable (provided, that the Purchaser shall not consent to the entry of any judgment or settlement with respect to any such Proceeding without the prior written approval of the Company, not to be unreasonably     
 withheld, conditioned or delayed); and                                                                                                                                                                                                               |

| (v) | not take any action, or refrain from taking any commercially reasonable action, or permit any action to be 
 taken or not taken, in each case, which is inconsistent with this Agreement or                             |

- 31 -

| which would reasonably be expected to prevent, materially delay or otherwise impede the consummation of the Arrangement or the transactions contemplated by this Agreement. |

| (b) | The Purchaser shall promptly notify the Company in writing of: |

| (i) | unless prohibited by Law, any written notice or other written communication, of which the Purchaser and/or the                                                                                                                                          
 Parent has knowledge, from any person alleging that the consent (or waiver, permit, exemption, order, approval, agreement, amendment or confirmation) of such person (or another person) is or may be required in connection with the Arrangement, this 
 Agreement or any of the transactions contemplated thereby; or                                                                                                                                                                                           |

| (ii) | any Proceedings commenced or, to the knowledge of the Purchaser and/or the Parent, threatened against, relating                                                                                                                                         
 to or involving or otherwise affecting the Arrangement, this Agreement or any of the transactions contemplated hereby, in each case to the extent that such Proceedings would reasonably be expected to impair, impede, materially delay or prevent the 
 Purchaser and/or the Parent from performing its obligations under this Agreement.                                                                                                                                                                       |

| 5.5 | Information Rights; Confidentiality |

During the Interim Period, upon reasonable notice, the Company shall, and shall cause its Representatives to, provide the Purchaser and its Representatives with reasonable access (without material disruption to the conduct of the Company’s business and subject to any applicable competition laws) during normal business hours to all books, records, information, corporate charts, tax documents, filings, memoranda, working papers and files and all other materials in its possession and control, including Material Contracts, and access to the personnel of and legal counsel to the Company and its Subsidiary on an as reasonably requested basis as well as reasonable access to the properties of the Company and its Subsidiary, in each case, to the extent reasonably necessary to consummate the transactions contemplated by